ISMAILIA — Egypt plans to channel investments of up to EGP 12 billion (approximately $240 million) into its Vaccine and Biotechnology City by 2030 as Cairo seeks to strengthen pharmaceutical self-sufficiency, reduce reliance on imported vaccines and position itself as a regional manufacturing hub serving African and Middle Eastern markets. The project forms part of a broader strategy [...] The post Egypt Bets EGP 12bn on Vaccine Hub to Cut Imports and Expand Regional Reach appeared first on The Middle East Observer .
